Page last updated: 2024-10-26

droperidol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

droperidol has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

Droperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
droperidol : An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ting, JY1

Other Studies

1 other study available for droperidol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult.
    Clinical toxicology (Philadelphia, Pa.), 2007, Volume: 45, Issue:4

    Topics: Acute Disease; Adult; Antipsychotic Agents; Blood Pressure; Cannabinoids; Cannabis; Cardiomyopathies

2007